
Share on:
MRPC, a single-source provider of medical device components and assemblies, has created significant quality improvements for two clients that brought production of their molded components back to the U.S. from offshore manufacturers.
While these clients initially transitioned their manufacturing productions to offshore molders to drive cost savings, they quickly realized that these savings were achieved at the expense of component quality, may be negligible when the expense of international shipping is factored in and may present challenges for highly regulated industries, where material quality and certifications must be factored into the production process. (Source: MRPC)
RELATED ARTICLES
Kapstone Manufacturing to Integrate In-House DLyte Dry Electropolishing
Jun 04 2026 , Julie A. Vetalice
5 Packaging Validation Mistakes That Delay FDA Clearance
Jun 01 2026 , Matthew Emerick
Small Joint Implants: A New Era with Medureon™ Bionate™
Jun 01 2026 , dsm -firmenich



